STRATEC Biomedical AG: Release according to Article 26, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
STRATEC Biomedical AG
23.05.2012 14:30
Dissemination of a Voting Rights Announcement, transmitted by
DGAP - a company of EquityStory AG.
The issuer is solely responsible for the content of this announcement.
Ameriprise Financial, Inc., Minneapolis, Minnesota, USA, has notified us
pursuant to sec. 21 para. 1 WpHG on 22 May 2012, that on 18 May 2012 the
share of voting rights in STRATEC Biomedical AG, Birkenfeld, Germany, ISIN:
DE0007289001 went above the threshold of 5% and that the percentage of
voting rights on that day amounted to 5.02% (586,136 shares). These voting
rights are attributable to Ameriprise Financial, Inc. pursuant to sec. 22
para. 1 sent. 1 no. 6 in connection with sent. 2 WpHG.
23.05.2012 DGAP's Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de
Language: English
Company: STRATEC Biomedical AG
Gewerbestr. 37
75217 Birkenfeld
Germany
Internet: www.stratec.com
End of Announcement DGAP News-Service
back